MoneyWorks4Me

Fischer rises as its arm wins Catanduanes Integrated Digital Healthcare Project

25 Aug 2026 Evaluate

Fischer Medical Ventures is currently trading at Rs. 36.82, up by 0.18 points or 0.49% from its previous closing of Rs. 36.64 on the BSE.

The scrip opened at Rs. 35.60 and has touched a high and low of Rs. 37.07 and Rs. 35.60 respectively. So far 21309 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 124.20 on 24-Sep-2025 and a 52 week low of Rs. 31.13 on 09-Jun-2026.

Last one week high and low of the scrip stood at Rs. 39.97 and Rs. 35.60 respectively. The current market cap of the company is Rs. 2572.56 crore.

The promoters holding in the company stood at 62.15%, while Institutions and Non-Institutions held 6.83% and 31.02% respectively.

Fischer Medical Ventures’ step-down subsidiary-- Time Medical Philippines (TM-P) has been awarded the Catanduanes Province project to strengthen digital healthcare delivery and support the digitalization of Universal Health Care across the province. Together with its digital health partner, FlynnCare, TM-P will deploy an integrated healthcare solution combining Health Kiosks with the PhilHealth-accredited FlynnCare Clinic Management System (CMS), connecting community-level healthcare delivery with structured digital clinical workflows and patient information.

This integrated approach is particularly important for municipalities and barangays where access to comprehensive healthcare services and diagnostic infrastructure may be limited. By bringing together community-level screening, connected diagnostics, digital clinical workflows and teleconsultation, the solution is designed to bring healthcare closer to communities while strengthening coordination between frontline healthcare providers and the broader healthcare system.

The Catanduanes rollout also demonstrates how digital technology can support the objectives of the Philippines’ Universal Health Care program. Connecting community healthcare delivery with a PhilHealth-accredited CMS provides a foundation for more standardized clinical workflows, structured patient information and improved continuity of care, supporting a healthcare environment that is increasingly accessible, connected, coordinated and data-driven.

Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.

Fischer Medical Share Price

36.09 0.78 (2.21%)
28-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 365.85
Amrapali Industries 33.14
Adani Enterprises 3166.00
Rashi Peripheral 829.70
PDS 369.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: